SCHEMBL537792

SCHEMBL537792

Clc1ccccc1CN1CCN(c2nc3c4c(n2)N(Cc2ccccc2)CCC4NN3)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.46
ALDH1A1 P00352 6/20 0.43
KDM4E B2RXH2 4/20 0.43
HTT P42858 1/20 0.43
ATM Q13315 1/20 0.43
PLA2G1B P04054 1/20 0.41
RAB9A P51151 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41
KMT2A Q03164 2/20 0.40
CXCR4 P61073 2/20 0.39
MAPT P10636 2/20 0.39
GAA P10253 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
BCL2L1 Q07817 1/20 0.38
CASP1 P29466 1/20 0.38
CASP5 P51878 1/20 0.38
GALR3 O60755 1/20 0.38
NR2F2 P24468 1/20 0.38
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2810802 0.87 CASP1 (0.43) SIGMAR1ALDH1A1KDM4EHTTCXCR4
SCHEMBL2812365 0.85 DRD4 (0.39) ALDH1A1KDM4EHTTMAPTGAA
SCHEMBL2810547 0.85 KDM4E (0.43) ALDH1A1KDM4EHTTKMT2AMAPT
SCHEMBL2809650 0.84 ALDH1A1 (0.40) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL2809502 0.84 HTR6 (0.41) ALDH1A1KDM4EHTTRAB9A
SCHEMBL2808374 0.84 CASP1 (0.47) SIGMAR1ALDH1A1KDM4EHTTMAPT
SCHEMBL2810582 0.84 ALDH1A1 (0.45) SIGMAR1ALDH1A1KDM4EGAASMN1; SMN2
SCHEMBL2812041 0.84 CASP1 (0.40) ALDH1A1KDM4EHTTKMT2AGAA
SCHEMBL2811977 0.84 HCAR2 (0.36) KDM4EHTTMAPTGAACASP1
SCHEMBL2814053 0.84 SIGMAR1 (0.48) SIGMAR1ALDH1A1KDM4EHTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
EP-2414359-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ArQule, Inc. (US) 2012-02-08 EP disclosed
WO-2010114905-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-10-07 WO disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 SIGMAR1 4535/4885ALDH1A1 924/4885KDM4E 2749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.